Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine (VLA2001) to volunteers in phase 3 study
Panthera has started vaccinating volunteers in Valneva’s double-blind, phase three, COVID prevention trial. The trial will compare Valneva’s inactivated vaccine, VLA2001, with AstraZeneca’s conditionally approved vaccine Vaxzeria. Unlike earlier COVID-19…
INCENTIVE QAS EXTENDS CONTRACT FOR TOWER PLACE, LONDON
Incentive QAS has secured a major contract extension to continue to provide a range of services for the prestigious Tower Place which is located next to the Tower of London.…
Coronavirus (COVID-19) Information for our Samsung UK Community
The Global Coronavirus (COVID-19) situation is an unprecedented moment, affecting almost every aspect of daily life. First and foremost, our thoughts are with all those affected. We have taken considerable…